Established Sidmak USA - Manufacturing of sustained release OTC products.
Implemented Aggressive R&D program for generics.
Received several generic products approvals and began marketing those products.
Sidmak USA also established medisol Laboratories Inc :Generic prescription aerosols
Acquired - Advanced Remedies Inc : A company to develop and . market Generic ophthalmic products 1993 – Completed a strategic alliance with a soft gelatin capsule manufacturer and Sidmak USA developed prescription soft gelatin products.
$ 15 million private placement was successfully completed
Established Odyssey Pharma, a brand marketing subsidiary of Sidmak USA and acquired few brand name products from MNC’s and quickly accomplished close to $50Milion in brand marketing.
Started Sidmak India At Valsad As a Domestic Plan.
Many modified release products were developed using various Technology Platform.
Established a separate R&D facility and started offering contract development services to US customers.
Developed and successfully tech transferred three solid oral products to US customer’s facility in USA, and ten liquid oral tech transferred to another US customer.
Started construction of new US FDA compliant facility in Dehradun and completed 2005.
Sidmak India Developed and received DCGI (Drug Controller General of India ) approvals for about half a dozen new products and began manufacturing these products for leading companies in India.
7745.293 Sq. Meter scale-up and commercial manufacturing facility is located at Dehradun (near New Delhi). Dehradun facility is WHO and US-FDA approved. This facility has been serving the export and domestic customers, including the major Indian Pharma companies.
USFDA Approval Sidmak DDN site .